JDR Woodhead Publishing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stojic, D.
Right arrow Articles by Grbovic, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stojic, D.
Right arrow Articles by Grbovic, L.
J Dent Res 86(6):565-570, 2007
© 2007 International and American Associations for Dental Research


RESEARCH REPORT
Biological

Responses of the Human Submandibular Artery to ACh and VIP

D. Stojic1,*, S. Pesic2, M. Radenkovic3, J. Popovic-Roganovic1, Z. Pesic4, and L. Grbovic3

1 Department of Pharmacology, Faculty of Stomatology, University of Belgrade, Dr. Subotica br. 8, 11 000 Belgrade;
2 Department of Pharmacology, Medical Faculty, University of Nis;
3 Department of Pharmacology, Clinical Pharmacology and Toxicology, Medical Faculty, University of Belgrade; and
4 Department of Maxillofacial Surgery, Medical Faculty, University of Nis, Serbia and Montenegro

* corresponding author, miona-25{at}beotel.yu

Endothelial vasodilatory substances may play a central role in the local regulation of vascular tone. We hypothesized that these substances can mediate endothelium-dependent vasodilatory responses to acetylcholine (ACh) and vasoactive intestinal peptide (VIP) in the human submandibular artery. We evaluated the contributions of endothelial vasodilatory substances to vessel relaxation in response to ACh and VIP, using different inhibitors of endothelial vasodilation, the nitric oxide synthase inhibitor, the cyclo-oxygenase inhibitor, indomethacin, the potassium channel blocker, and 4-aminopyridine. ACh and VIP caused an endothelium- and concentration-dependent relaxation in this artery. ACh relaxation was completely blocked after the concomitant addition of NG-nitro-L-arginine and indomethacin. The vasorelaxant effect of ACh was not influenced by 4-aminopyridine. VIP relaxation was almost completely abolished by 4-aminopyridine, and was partly inhibited by NG-nitro-L-arginine, but was not affected by indomethacin. Thus, in the human submandibular artery, ACh and VIP produced endothelium-dependent vasodilation with different underlying mechanisms: release of nitric oxide (NO) and cyclo-oxygenase products for ACh, and release of NO and endothelium-derived hyperpolarizing factor for VIP.

KEY WORDS: ACh • VIP • human submandibular artery







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2007 Institutional Access Guidelines